Form 8-K - Current report:
SEC Accession No. 0001564590-21-036581
Filing Date
2021-07-14
Accepted
2021-07-14 17:00:45
Documents
12
Period of Report
2021-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prtk-8k_20210714.htm   iXBRL 8-K 42890
  Complete submission text file 0001564590-21-036581.txt   169191

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prtk-20210714.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20210714_lab.xml EX-101.LAB 18717
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20210714_pre.xml EX-101.PRE 11176
5 EXTRACTED XBRL INSTANCE DOCUMENT prtk-8k_20210714_htm.xml XML 3419
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 211090766
SIC: 2834 Pharmaceutical Preparations